Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan D van Zuilen

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Nephrology|July 1, 2008
MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patientsArjan D Van Zuilen, Jack F M Wetzels, Michiel L Bots, et al.
Human Immunology|December 13, 2012
Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantationHenny G Otten, Jorg J A Calis, Can Keşmir, et al.
Frontiers in Immunology|June 6, 2018
Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant OutcomeLaura A Michielsen, Arjan D van Zuilen, Tineke Kardol-Hoefnagel, et al.
Transplantation Reviews (Orlando, Fla.)|July 11, 2016
Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma?Laura A Michielsen, Arjan D van Zuilen, Merle M Krebber, et al.
AIDS Patient Care and Stds|October 3, 2012
Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a reviewErik M van Maarseveen, Christin C Rogers, Jennifer Trofe-Clark, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney DiseaseEsther de Beus, Michiel L Bots, Arjan D van Zuilen, et al.
Journal of Renal Care|May 7, 2015
EVALUATION OF THE ROLE OF NURSE PRACTITIONERS IN MASTERPLANJudith M Wierdsma, Sigrid C J M Vervoort, Arjan D van Zuilen, et al.
HLA|October 21, 2022
Complement component C3 and C5b-9 deposition on hypoxia reperfused endothelial cells by non-HLA antibodies against RhoGDI2: A player involved in graft failure?Tineke Kardol-Hoefnagel, Laura A Michielsen, Anna M Ehlers, et al.
Clinical Pharmacokinetics|May 10, 2020
Early Estimation of Renal Function After Transplantation to Enable Appropriate Dosing of Critical Drugs: Retrospective Analysis of 103 Patients in a Single CenterTobias T Pieters, Paul Beele, Arjan D Van Zuilen, et al.
Transplantation|December 20, 2012
Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot studyErik M van Maarseveen, Heleen A Crommelin, Tania Mudrikova, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Nephrology|July 1, 2008
MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patientsArjan D Van Zuilen, Jack F M Wetzels, Michiel L Bots, et al.
Human Immunology|December 13, 2012
Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantationHenny G Otten, Jorg J A Calis, Can Keşmir, et al.
Frontiers in Immunology|June 6, 2018
Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant OutcomeLaura A Michielsen, Arjan D van Zuilen, Tineke Kardol-Hoefnagel, et al.
Transplantation Reviews (Orlando, Fla.)|July 11, 2016
Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma?Laura A Michielsen, Arjan D van Zuilen, Merle M Krebber, et al.
AIDS Patient Care and Stds|October 3, 2012
Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a reviewErik M van Maarseveen, Christin C Rogers, Jennifer Trofe-Clark, et al.
Hypertension (Dallas, Tex. : 1979)|September 10, 2015
Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney DiseaseEsther de Beus, Michiel L Bots, Arjan D van Zuilen, et al.
Journal of Renal Care|May 7, 2015
EVALUATION OF THE ROLE OF NURSE PRACTITIONERS IN MASTERPLANJudith M Wierdsma, Sigrid C J M Vervoort, Arjan D van Zuilen, et al.
HLA|October 21, 2022
Complement component C3 and C5b-9 deposition on hypoxia reperfused endothelial cells by non-HLA antibodies against RhoGDI2: A player involved in graft failure?Tineke Kardol-Hoefnagel, Laura A Michielsen, Anna M Ehlers, et al.
Clinical Pharmacokinetics|May 10, 2020
Early Estimation of Renal Function After Transplantation to Enable Appropriate Dosing of Critical Drugs: Retrospective Analysis of 103 Patients in a Single CenterTobias T Pieters, Paul Beele, Arjan D Van Zuilen, et al.
Transplantation|December 20, 2012
Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot studyErik M van Maarseveen, Heleen A Crommelin, Tania Mudrikova, et al.
Pageof 9